SCHEMBL24256905

SCHEMBL24256905

CCCc1nc2sc(C=O)c(N)c2c2c1CCC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.48
ATM Q13315 4/20 0.48
GLA P06280 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
CDK8 P49336 1/20 0.48
CDK19 Q9BWU1 1/20 0.48
ALDH1A1 P00352 8/20 0.44
GAA P10253 7/20 0.44
HPGD P15428 6/20 0.44
POLB P06746 3/20 0.43
RXFP1 Q9HBX9 1/20 0.43
ALOX15 P16050 1/20 0.39
MAPK1 P28482 3/20 0.39
TSHR P16473 3/20 0.39
MAPT P10636 5/20 0.37
HTT P42858 3/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 2/20 0.36
RAD52 P43351 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24256648 0.79 KDM4E (0.62) KDM4EATMGLAL3MBTL1CDK8
SCHEMBL24256646 0.75 KDM4E (0.77) KDM4EATMGLAL3MBTL1CDK8
SCHEMBL24256384 0.66 ALDH1A1 (0.48) KDM4EATMGLAL3MBTL1CDK8
SCHEMBL24256381 0.66 ALDH1A1 (0.48) KDM4EATMGLAL3MBTL1CDK8
SCHEMBL24256851 0.65 HPGD (0.74) KDM4EL3MBTL1ALDH1A1HPGDPOLB
SCHEMBL18848994 0.65 CDK8 (1.00) KDM4EATMGLAL3MBTL1CDK8
SCHEMBL18537695 0.64 MAPT (0.69) KDM4EL3MBTL1ALDH1A1GAAHPGD
SCHEMBL24256903 0.63 KDM4E (0.56) KDM4EATMGLAL3MBTL1CDK8
SCHEMBL18537593 0.63 KDM4E (0.57) KDM4EATMGLAALDH1A1GAA
SCHEMBL24256383 0.63 ALDH1A1 (0.59) KDM4EL3MBTL1ALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035806-A1 FUSED TRICYCLIC PYRIMIDINE-THIENO-PYRIDINE SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed